Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Algisys

Explore full profile

Algisys produces algal oils and high protein additives for the supplement, food, beverage, pharmaceutical and animal feed markets

Edinburgh, United KingdomFounded 2009Biotech & Life Sciences
Valuation $250–500M Last recorded · 2021
Headcount <100 Current team size
Total funding $50–100M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for Algisys and the history behind them.

About Algisys

AlgiSys is a biotechnology startup that specializes in the production of high-quality Omega-3 Algal EPA (EicosaPentaenoic Acid) using proprietary strains of algae. The company operates in the multi-billion dollar omega-3 fatty acids market, which has a high demand for EPA and DHA (DocosaHexaenoic Acid), two of the most beneficial forms of omega-3 fatty acids.

AlgiSys's business model revolves around the production of all-natural EPA Omega-3 nutritional oils and high protein vegan biomass. The company's target clients are primarily in the health and wellness sector, which includes individuals and businesses interested in nutritional supplements and vegan protein sources.

The company's unique selling point is its proprietary microalgae, which are heterotrophic producers of EPA. This means they can grow quickly in the dark using fermentation technology. By employing traditional industrial fermentation equipment, AlgiSys can efficiently scale and accelerate the microalgae's natural oil production time to just a few days at commercial levels.

AlgiSys has developed the first commercial algal EPA production process to cost-effectively produce this important omega-3 fatty acid. The company aims to play a significant role in meeting the rapidly growing demand for EPA and high protein biomass products using its exclusive biotechnology.

In summary, AlgiSys is a biotech startup that leverages proprietary technology to produce high-quality Omega-3 Algal EPA and high protein vegan biomass, targeting the health and wellness market.

Source: Dealroom company data

At a glance

Status
Operational
Founded
2009
Headquarters
Edinburgh, United Kingdom
Employees
8
Open positions
None listed
Dealroom signal
74.7/100
Industry
Health, Wellness Beauty
Sub-industry
BioTechnology
Sector
Biotech & Life Sciences, Biotechnology, Algae, Biotech and Pharma, proteomics, DT and LS, science-based
Business model
Manufacturing
Client focus
b2c

Funding history

4 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES BOther financing Nov 2021 $45M $180M The Peakstone Group —
SERIES AOther financing Aug 2013 $6.2M $25M Undisclosed —
Showing the latest 2 of 4 recorded eventsBook a demo for the full funding history →

Growth signals

Algisys website traffic

Latest recorded traffic for Algisys is 390 monthly website visits, down 72.1% over the last three months. Algisys's team grew 14.3% over the past year.

Latest monthly visits390 3-month web change-72.1% 1-year team growth+14.3%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Investors

1 investor on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A1 investor entered at this stage

  • The Peakstone Group
Team profiled 5 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 5 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
2 countries with
team presence
🇬🇧 United Kingdom50%
🇺🇸 United States50%
2 countries shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Algisys on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Algisys’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.